S100B and melanoma: Similar to preoperative levels, higher level of S100B in postoperative plasma sample (cut‐off value 0.1466 μg/L) was not predictive for patients’ DFI (p = 0.573), OS (p = 0.208), or melanoma recurrence (p = 0.438).